Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Director of Cardio-Oncology
DrAvirup Guha, Assistant Professor at Augusta University, leads Cardio-Oncology at the Medical College of Georgia, Augusta, US. Dr Guha's ongoing research, under the patronage of the American Heart Association and the Department of Defense, delves deep into the translational science concerning biological disparities between White and Black men with prostate cancer (PC) undergoing androgen… View more
Foreword

Article

Author(s): Juan Carlos Kaski Added: 3 years ago
This new issue of ECR features important contributions. There are three articles that deal with different aspects of non-ischemic cardiomyopathy and heart failure; two conditions that represent major clinical and public health problems. McDonagh’s paper on chemotherapy related cardiomyopathy will be of great interest to the practicing physician, together with Casu’s review on the rational use of… View more
Job title: Chief Science Officer
Author(s): Axel Pries , Stefan Stork Added: 6 years ago
Axel R. Pries discusses "Coronary microcirculatory pathophysiology: can we afford it to remain a black box?" at the 2016 ESC Congress in Rome, Italy. View more
Job title: Cardiac Imaging Fellow
Personal History Dr Abhishek Joshi is a Cardiologist based in London. He is a Cardiology Registrar at Barts Heart Centre and a Clinical Research Training Fellow at the British Heart Foundation. He holds a PhD in Cardiovascular Science from King’s College London. In his spare time, Dr Joshi plays the bass guitar and enjoys video games.2 Academic History In 2003, he obtained his BA… View more
Author(s): Kate Wilcox , David Preiss Added: 1 year ago
AHA 22 - Dr Kate Wilcox, CardioNerds Academic Fellow (Medical College of Wisconsin, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Dr David L Preiss(University of Oxford, UK), investigator of the late-breaking EMPA-Kidney trial (NCT03594110). The trial, first presented AHA 22, looked at the SGLT2i, empagliflozin's (Boehringer Ingelheim)effect on… View more
Foreword

Article

Author(s): Juan Carlos Kaski Added: 3 years ago
Welcome to the December 2017 issue of European Cardiology Review. In this issue, we present a section on heart failure and cardiomyopathies featuring articles from A. Bayes-Genis and A. Malhotra and S. Sharma. Professor Bayes-Genis highlights the latest changes introduced to the European Society of Cardiology guidelines on the management of heart failure, whereas Dr Malhotra and Sharma’s… View more
Job title: Lead Nurse and Director of Clinical Services
At UK Vein Clinic, Vanessa supports patients during their procedures and also leads the clinical pathway and aftercare team.Vanessa was born and raised in California, where she initially attended UC Berkeley for a BA in History, before she went on to complete a Bachelor of Nursing degree at the University of Glasgow. With a background in cardiovascular theatre nursing, Vanessa worked at St Thomas… View more
Billy A. Caceres, PhD, RN, FAHA, FAAN is an Assistant Professor at the School of Nursing and the Center for Sexual and Gender Minority Health Research at Columbia University. Caceres is also an affiliated investigator of the Center for Research on People of Color and the Precision in Symptom Self-Management (PriSSM) Center at Columbia University School of Nursing. Caceres completed his PhD at the… View more
Author(s): Iana Simova Added: 3 years ago
Coronary flow velocity reserve (CFVR) represents the ratio between maximal (stimulated) coronary blood flow, induced by using a coronary vasodilator, and baseline (resting) blood flow (see Figure 1). As a ratio it is a dimensionless variable. It could be measured with different tools – some of them, such as intracoronary Doppler flow wire and coronary sinus thermodilution, are invasive methods… View more